Article
04 Feb 2025
FDA Reopens Door For Flavored Cigars And Menthol Cigarettes
AUTHORS CONTENT
Article
31 Jan 2025
Tirzepatide, FDA, And Compounding: Understanding The Current Landscape
Article
29 Jan 2025
Navigating The FDA's Final Interim Policy On Compounding With Bulk Drug Substances: A Guide For 503A Pharmacies And 503B Outsourcing Facilities
Article
20 Jan 2025
4 Potential FDA Drug Approvals To Watch In 2025
Article
17 Dec 2024
FDA Issues 115 Warning Letters To Retailers Selling Unauthorized E-Cigarettes
Article
26 Nov 2024
Tirzapatine Shortage Status Unchanged
Article
17 Oct 2024
FDA's CDRH Issues Guidance Priorities For Next Year, Including Guidances On LDTs, AI, And Cybersecurity
Article
14 Oct 2024
Association Sues FDA To Stop Removal Of Compounded Weight-Loss Drug
Article
14 Oct 2024
FDA Grants Extension For Certain Companies To Comply With DSCSA
Article
14 Oct 2024
Eli Lilly Looks To Medical Records To Go After Compounders
Article
03 Oct 2024
Senator Wyden Proposes Legislation To Regulate Hemp-Derived Cannabis As Distinct Product Class
Article
18 Jun 2024
DeSantis Vetoes Bill That Would Have Banned Some Delta-8 THC Products
Article
24 Apr 2024
Change Is Afoot For The Cannabis Landscape In Florida
Article
07 Nov 2023
White House Issues Groundbreaking Executive Order On Artificial Intelligence
Article
17 Oct 2023
Artificial Intelligence And Machine Learning: The Next Frontier Of Drug Development?
Article
11 Sep 2023
Adjusting Position: HHS Recommends The Rescheduling Of Marijuana Under The CSA
Article
17 Aug 2023
Key Steps To Prepare for FDA's New Medical Device Cybersecurity Rules
Article
13 Jul 2023
FDA And FTC Issue Warning To Six Companies Selling Delta-8 THC Products
Article
17 Feb 2023
2023 Is Set To Bring A Wave Of COVID-19 Fraud Enforcement In Life Sciences
Article
07 Jun 2022
Court Rules Delta-8 THC Products Now Legal